These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 863167)

  • 21. Occurrence of lactosylsphingosine-reactive antibodies in sera of cancer patients.
    Jóźwiak W; Kościelak J
    Acta Haematol Pol; 1980; 11(3):173-9. PubMed ID: 7445920
    [No Abstract]   [Full Text] [Related]  

  • 22. Sperm-associated antigen 9 is a biomarker for early cervical carcinoma.
    Garg M; Kanojia D; Salhan S; Suri S; Gupta A; Lohiya NK; Suri A
    Cancer; 2009 Jun; 115(12):2671-83. PubMed ID: 19326449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-immunologic changes in patients with cervical cancer after treatment with thymalin].
    Dekster LI; Nikolaeva LIa; Bokhman IaV; Letskiĭ VB; Morozov VG
    Vopr Onkol; 1984; 30(3):29-32. PubMed ID: 6608824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of radiosensitivity of cancer of the cervix].
    Dubrauszky V; Rotte K
    Strahlentherapie; 1971 Apr; 141(4):390-5. PubMed ID: 5557112
    [No Abstract]   [Full Text] [Related]  

  • 25. [Progress in immunological studies of women with genital neoplasms].
    Paruch J
    Przegl Lek; 1982; 39(6):441-7. PubMed ID: 6753040
    [No Abstract]   [Full Text] [Related]  

  • 26. [Determination of circulating immune complexes and associated parameters in patients with cervix uteri cancer].
    Orozco-Cruz R; Aguilar-Santelises M; Rodríguez-Coquiez G; Estrada Parra S
    Rev Latinoam Microbiol; 1987; 29(2):145-51. PubMed ID: 3438604
    [No Abstract]   [Full Text] [Related]  

  • 27. The radiation effects on humoral immune response in carcinoma of the uterine cervix.
    Chander S; Chandra M; Aggarwal N
    Indian J Pathol Microbiol; 1987 Oct; 30(4):389-95. PubMed ID: 3507397
    [No Abstract]   [Full Text] [Related]  

  • 28. [Morphological criteria of radiation therapy effectiveness in cervical cancer].
    Zharinov GM
    Vopr Onkol; 1980; 26(5):29-32. PubMed ID: 7385711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of the combined radiation therapy of cervical cancer using intracavitary gamma therapy].
    Vishnevskaia EE
    Vopr Onkol; 1982; 28(6):68-72. PubMed ID: 7090301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The application of Manchester method to the treatment of patients with stage 3 cancer of the cervix.
    Hliniakowa I; Woźniakowska Z
    Radiobiol Radiother (Berl); 1971; 12(1):3-5. PubMed ID: 5099413
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental validation and the initial experience of the use of intravenous laser irradiation of the blood in oncology].
    Gamaleia NF; Stadnik VIa; Rudykh ZM; Kosinskaia NP; Shtykhir' SV
    Eksp Onkol; 1988; 10(2):60-3. PubMed ID: 3391124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of the radiation treatment of the cervix uteri and uterine cancer in advanced age].
    Woraschk A; Glück S; Seifert B
    Zentralbl Gynakol; 1974 Oct; 96(41):1300-4. PubMed ID: 4617463
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy.
    Pongnikorn S; Fongmoon D; Kasinrerk W; Limtrakul PN
    J Med Assoc Thai; 2003 Jan; 86(1):61-8. PubMed ID: 12678140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results and complications in the treatment of cervix uteri cancer. Critical review of 599 cases].
    Bergonzini R; Balli M; Pompei G
    Minerva Ginecol; 1972 Feb; 24(2):51-6. PubMed ID: 4671822
    [No Abstract]   [Full Text] [Related]  

  • 35. [Soundness of combined and complex radiation therapy in I-stage cervical cancer from the viewpoint of late results and patient work rehabilitation].
    Vishnevskaia EE
    Vopr Onkol; 1981; 27(6):18-21. PubMed ID: 7269413
    [No Abstract]   [Full Text] [Related]  

  • 36. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 37. Herpes simplex type 2 and cervical cancer: immunological and in situ hybridization studies.
    Simard R; Kessous A; Mansour M; Camonis J; Rawls WE
    Prog Clin Biol Res; 1983; 132D():461-9. PubMed ID: 6314363
    [No Abstract]   [Full Text] [Related]  

  • 38. [Superselective transcatheter-arterial-chemo-embolization in uterine cervical cancer].
    Matsui Y; Kanoh H; Okudaira Y; Hashimoto T; Nakamura H
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2801-4. PubMed ID: 2551223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Experience in the treatment of early forms of cancer of the cervix uteri].
    Iatskovasaia NL
    Vopr Onkol; 1976; 22(2):95-7. PubMed ID: 1274273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of experimental hose apparatus "Agat-B" for combined radiation treatment of cervical cancer].
    Kiseleva VN; Ruderman AI; Novikova LA; Bal'ter SA; Vaĭnberg MSh
    Med Radiol (Mosk); 1976 May; 21(5):41-50. PubMed ID: 972585
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.